Drug Profile
Rosuvastatin/telmisartan - Biocon
Alternative Names: Telmisartan/rosuvastatin - BioconLatest Information Update: 19 Feb 2016
Price :
$50
*
At a glance
- Originator Biocon
- Class Antihyperlipidaemics; Antihypertensives; Benzimidazoles; Benzoates; Fluorobenzenes; Pyrimidines; Small molecules; Sulfonamides
- Mechanism of Action ACE inhibitors; Angiotensin type 2 receptor antagonists; HMG-CoA reductase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Hypertension
Most Recent Events
- 18 Feb 2016 No development reported - Phase-III for Hypertension in India (PO)
- 20 Jan 2012 Phase-III clinical trials in Hypertension in India (PO)